Danaher falls after cutting annual revenue growth forecast

Illumina

21/07/2026 13:11

Updates
** Shares of lab equipment maker Danaher DHR.N fall 11.6% to $177.75 premarket
** Co expects its 2026 adjusted core revenue to increase between 3% and 4%, vs. previous expectations of 3% to 6% y/y
** Reports Q2 adj. profit of $1.94/share, vs. analysts' average estimate of $1.83/share - LSEG data
** Q2 revenue of $6.27 billion beats expectations of $6.10 billion
** Forecasts Q3 adjusted core revenue growth of 2% to 3% y/y, below Street expectations of 3.5%, according to RBC Capital Markets analysts
** Raises annual adjusted earnings forecast to a range of $8.45 to $8.60 per share, compared with previous forecast of $8.35 to $8.55
** Peer Agilent Technologies A.N slips 4.8% before the bell, while Thermo Fisher Scientific TMO.N, Revvity RVTY.N and Illumina ILMN.O decline about 2% each
** As of last close, DHR down 12.2% YTD

(Reporting by Christy Santhosh and Kamal Choudhury)
((Christy.Santhosh@thomsonreuters.com))